Concepedia

Steven Hubert

SH

Statistics

Publications

4

Citations

140

H-Index

4

Active since

2016

Affiliations

Synthetic Biologics (United States)(Current)

Steven Hubert is an author at Synthetic Biologics (United States) specializing in pharmacology, pharmacy, and beta-lactamase inhibitors.

Publications per year

2016–2017

4

Publications

4

Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection

Michael Kaleko, J. Andrew Bristol, Steven Hubert et al. · Anaerobe · 2016 · 71 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies

Tracey Roberts, John F. Kokai‐Kun, Olivia Coughlin et al. · Clinical Drug Investigation · 2016 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +14

Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation

Steven Hubert, A. V. Chadwick, Vince Wacher et al. · Journal of Pharmaceutical Sciences · 2017 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon

Andrew Bristol, Steven Hubert, Felix Hofmann et al. · International Journal of Pharmaceutics · 2017 · 13 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–4 of 4